Global Market Study on Glycobiology: Rising Application of Glycobiology Enzymes for Novel Drug Development to Boost Demand

Glycobiology  Market
  • Published On : Aug-2020 |
  • Pages : 300 Pages |
  • Format : Glycobiology  Market Glycobiology  Market Glycobiology  Market Glycobiology  Market

Glycobiology is the pursuit to decipher information communicated by carbohydrate molecules – the carbohydrate code or glycocode. Glycans or carbohydrates are one of the fundamental classes of macromolecules present in biological systems, and are formed by individual sugar units called monosaccharides, linked to each other in multiple ways. Glycans are involved in every aspect of the biochemistry of life, in a way that proteins and peptides cannot be evaluated without understanding the science that deals with the study of synthesis, structural elucidation, functional property identification, and mechanism of interaction of glycans with biological molecules such as lipids and proteins. The global glycobiology market size is projected to expand more than threefold over the next ten years (2020 to 2030).

Glycobiology Market Trends

Chronic diseases such as cancer and diabetes have become a major reason for increasing research in the field of drug development, which is leading to increasing R&D expenditure by pharmaceutical companies, thus boosting revenue growth of the global glycobiology market. Increasing funding through government bodies is expected to boost revenue growth of the market over the forecast period. Factors such as continuous technological advancements, and availability of products to conduct protocol with high specificity and sensitivity, are expected to boost revenue growth of the global glycobiology market over the years ahead. However, factors such as high product cost and low availability of skilled professionals is expected to hamper revenue growth of the global glycobiology market in the future.

Regional Analysis of Glycobiology Market

At nearly 45%, North America is projected to retain its dominance over the global glycobiology market share through 2030. The market in the U.S. is expected to remain dominant for glycobiology in the North America glycobiology market. Europe is set to remain the second-largest market for glycobiology over the forecast period. The APAC region is expected to witness high growth, majorly due to increasing number of research initiatives being conducted in countries such as Japan and China.

COVID-19 Impact on Glycobiology Market

The most unprecedented operational and economic challenges have emerged as a result of the COVID-19 pandemic across the world. Significant time will be required to develop and commercialize effective treatment options for new coronavirus pathogens. These collective challenges are estimated to slow down industrial and academic research of cancer and diabetes conditions in the coming quarters of 2020 and 2021. In addition, local governments are prioritizing healthcare resources to tackle COVID-19 pandemic challenges, which is also expected to slow down the glycobiology market growth in the short-term.

The global glycobiology market is expected to experience short-term slowdown, followed by market recovery to pre-pandemic demand in the second half of 2021, owing to the availability of a COVID-19 vaccine and treatment by then. This will reflect in terms of the recovery of developed and emerging economies from COVID-19.

Analysts’ Viewpoint

The global glycobiology market is projected to expand at a rapid pace over the next ten years, and grow 3.5X its current size by the year 2030. Market players can look to the North American region, especially the U.S., for increasing their market share and profits, as this region will continue to dominate the global glycobiology landscape right though the year 2030.

Glycobiology Market - Scope of the Report

Persistence Market Research (PMR) recently published a market study on the global glycobiology market. The study provides detailed assessment of key market dynamics, including the drivers, trends, opportunities restraints, and detailed information about the glycobiology market structure. The market study presents exclusive information about how the glycobiology market will grow during the forecast period (2020-2030).

Key indicators of market growth, which include Year-on-Year (Y-o-Y) growth of the market and compound annual growth rate (CAGR) are explained in PMR’s study in a comprehensive manner. Other information includes definitions, drivers, and opportunity analysis by region and by product, which helps in the deep understanding of the market segment details by researchers, suppliers, manufactures, and distributors. This information can help readers understand the quantitative growth prospects of the glycobiology market during the forecast period.

The study is relevant for manufacturers, physicians, suppliers, distributors, and investors, and can help them in developing appropriate strategies to grow in the market. Business researchers, shareholders, and industry experts can leverage the information and data presented in PMR’s study.

The study also includes statistics as well as facts related to macroeconomics factors that are impacting developments in the market. It also offers actionable insights based on the future trends in the glycobiology market. Furthermore, small businesses and new entrants in the glycobiology market too can make use of the information presented in this study, based on which, they can make appropriate business decisions in order to gain momentum in the market.

PMR’s study on the glycobiology market offers information divided into five important segments—product, enzyme, application, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Key Segments of Glycobiology Market




End User


  • Instruments
  • Enzymes
  • Consumables
  • Reagent Kits
  • Galactosidases
  • GlcNAc Transferases
  • Others
  • Drug Discovery and Development
  • Diagnostic Applications
  • Industrial Applications
  • Therapeutic Applications
  • Others
  • Biopharmaceutical Companies
  • Research Laboratories
  • Hospitals
  • Diagnostic Centers
  • Contract Research Organizations
  • Biotechnology Industries
  • Academic Institutes
  • Others
  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • MEA

Questions Answered in PMR’s Glycobiology Market Report

  • Which regions will continue to remain the most profitable regional markets for glycobiology market players?
  • Which factors will induce a change in the demand for glycobiology during the assessment period?
  • What are the different opportunities available for emerging players in the glycobiology market?
  • How are supply-side and demand-side drivers impacting the glycobiology market?
  • How will changing trends impact the glycobiology market?
  • How can market players capture the low-hanging opportunities in the glycobiology market in developed regions?
  • Which companies are leading the glycobiology market?
  • What are the winning strategies of stakeholders in the glycobiology market to upscale their position in this landscape?

Glycobiology Market: Research Methodology

In PMR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the glycobiology market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the glycobiology market study include statistics from government healthcare organizations, medicines journals, research journals, press releases, annual reports, white papers, directories, and databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the glycobiology market, and makes PMR’s projections on the growth prospects of the glycobiology market more accurate and reliable.

Companies covered in Glycobiology Market Report

  • Merck KGaA
  • Bio-Techne Corporation 
  • Bruker Corporation 
  • Thermo Fisher Scientific, Inc. 
  • Shimadzu Corporation 
  • ProZyme Inc.
  • NEB Inc.
  • Agilent Technologies
  • New England Biolabs
  • Takara Bio
  • Waters Corporation
  • Danaher Corporation
Back To Top